The COURAGE trial: Is there still a role for PCI in stable coronary artery disease?: Commentary

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 8, 2007, Pages 410-411

  King III, Spencer B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; CLOPIDOGREL; EZETIMIBE; FIBRIC ACID DERIVATIVE; ISOSORBIDE; METOPROLOL; NICOTINIC ACID; SIMVASTATIN;

ACUTE CORONARY SYNDROME; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SHORT SURVEY; STROKE; SYMPTOM; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 34547544511     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0939     Document Type: Short Survey

References (4)

1. Serruys PW et al. (2005) Five year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46: 575-581
2. Hueb W et al. (2007) Five year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS-II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 115: 1082-1089
3. King SB III (2005) Angioplasty is better than medical therapy for alleviating chronic angina pectoris. Arch Intern Med 165: 2589-2592
4. Valgimigli M et al. (2007) Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial. J Am Coll Cardiol 49: 431-441